Adams Diversified Equity Fund’s Idexx Laboratories IDXX Stock Holding History

Adams Diversified Equity Fund’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,100	Closed	-$14.1M	–	103
2024 Q1	$14.1M	Hold	26,100	–	–	0.5%	75
2023 Q4	$14.5M	Sell	26,100 -8,200	-24%	-$3.85M	0.57%	66
2023 Q3	$15M	Hold	34,300	–	–	0.64%	62
2023 Q2	$17.2M	Buy	+34,300	New	+$16.4M	0.72%	54
2022 Q2	–	Sell	-30,500	Closed	-$16.7M	–	99
2022 Q1	$16.7M	Buy	+30,500	New	+$16M	0.66%	58
2021 Q3	–	Sell	-39,300	Closed	-$24.8M	–	108
2021 Q2	$24.8M	Buy	39,300 +25,500	+185%	+$14.1M	0.98%	34
2021 Q1	$6.75M	Buy	+13,800	New	+$6.91M	0.29%	101

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adams Diversified Equity Fund's IDXX Position: Q2 2024 in Review

Adams Diversified Equity Fund sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 26,100 shares — an estimated $14.1M sold.

Adams Diversified Equity Fund first reported a position in IDXX in Q1 2021 and held it in 7 quarters. The position peaked at $24.8M in Q2 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Adams Diversified Equity Fund reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Adams Diversified Equity Fund sold 26,100 Idexx Laboratories shares in Q2 2024, an estimated $14.1M.
Adams Diversified Equity Fund first reported a position in Idexx Laboratories in Q1 2021 and held it in 7 quarters.
Adams Diversified Equity Fund's Idexx Laboratories position peaked at $24.8M in Q2 2021.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2024, filed 1 Aug 2024.